European drug regulators classify NAION as a 'very rare' side effect of semaglutide — the active ingredient in Ozempic, Wegovy. The risk often emerged after two years of use ...

Court says swift action on pharmaceutical crimes needed to maintain India’s position as ‘pharmacy of the world’.